Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Amyris revenue
Amyris's revenue is $269.8 million.
What is Amyris's revenue?
- Amyris's revenue growth from 2009 to 2022 is 317.67%.
- Amyris has 595 employees, and the revenue per employee ratio is $453,524.
- Amyris's peak quarterly revenue was $176.9M in 2021(q1).
- Amyris peak revenue was $341.8M in 2021.
- Amyris annual revenue for 2021 was 341.8M, 97.43% growth from 2020.
- Amyris annual revenue for 2022 was 269.8M, -21.06% growth from 2021.
On this page
Zippi applies for you, and finds you a job.
Amyris historical revenue
Amyris's peak revenue was $341.8M in 2021. The peak quarterly revenue was $176.9M in 2021(q1).
Amyris's revenue increased from $64.6m in 2009 to $269.8M currently. That's a 317.67% change in annual revenue.
Amyris annual revenue
Amyris annual revenue over time
| Fiscal year / year | Amyris revenue |
|---|---|
| 2009 | $64.6M |
| 2010 | $80.3M |
| 2011 | $147.0M |
| 2012 | $73.7M |
| 2013 | $41.1M |
| 2014 | $43.3M |
| 2015 | $34.2M |
| 2016 | $67.2M |
| 2017 | $127.7M |
| 2018 | $63.6M |
| 2019 | $152.6M |
| 2020 | $173.1M |
| 2021 | $341.8M |
| 2022 | $269.8M |
Rate Amyris' financial transparency
Amyris annual growth
Amyris saw the greatest revenue growth in 2019, when revenue increased by 139.85%.
Amyris had the lowest revenue growth in 2018, when revenue changed by -50.18%.
Amyris annual growth rate over time
| Year | Amyris growth |
|---|---|
| 2010 | 24%↑ |
| 2011 | 83%↑ |
| 2012 | -50%↓ |
| 2013 | -44%↓ |
| 2014 | 5%↑ |
| 2015 | -21%↓ |
| 2016 | 97%↑ |
| 2017 | 90%↑ |
| 2018 | -50%↓ |
| 2019 | 140%↑ |
| 2020 | 13%↑ |
| 2021 | 97%↑ |
| 2022 | -21%↓ |
Amyris quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Amyris quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2010 | - | - | $24.2M | $29.7M |
| 2011 | $37.2M | $32.0M | $36.3M | $41.5M |
| 2012 | $29.5M | $19.3M | $19.1M | $5.9M |
| 2013 | $7.9M | $10.8M | $7.0M | $15.4M |
| 2014 | $6.0M | $9.3M | $16.3M | $11.6M |
| 2015 | $7.9M | $7.8M | $8.6M | $9.8M |
| 2016 | $8.8M | $9.6M | $26.5M | $22.2M |
| 2017 | $13.0M | $25.7M | $24.2M | $64.8M |
| 2018 | $17.9M | $15.1M | $14.3M | $16.4M |
| 2019 | $14.4M | $62.7M | $35.0M | $40.5M |
| 2020 | $29.1M | $30.0M | $34.3M | $79.7M |
| 2021 | $176.9M | $52.3M | $47.9M | $64.8M |
| 2022 | $57.7M | $65.2M | $71.1M | $75.8M |
| 2023 | $56.1M | - | - | - |
Amyris jobs nearby
Do you work at Amyris?
Is Amyris transparent about its revenue structure?
Amyris financial information
| CEO | Mr. John G. Melo |
| Industry | Consumer Discretionary |
| Company Type | Public |
| Employees Number | 595 |
| Date Founded | 2003 |
| Headquarters | Emeryville, California |
| Number of Locations | 1 |
| Revenue | $269.8M |
| Net Income | -$528,510,000 |
| Gross Proft | $11.2M (2022) |
| PE Ratio | -0.57 |
| Tax Rate | 0.0% |
| Market Capitalization | $299.6M |
| Total Assets | $824,932,000 |
| Ticker | AMRS |
Amyris jobs you might like
Amyris financing
Amyris received early financing of $20.0M on 2006-10-12.
| Series | Round size | Date |
|---|---|---|
| Series A | $20M | 10/2006 |
| Series B | $70M | 09/2007 |
| Series Unknown | $2.4M | 02/2008 |
| Series B | $21M | 08/2008 |
| Series C | $41.8M | 10/2009 |
| Grant | $24.3M | 12/2009 |
| Series D | $133M | 06/2010 |
| Post Ipo Equity | $13.8M | 10/2010 |
| Post Ipo Equity | $7M | 10/2011 |
| Post Ipo Equity | $83.7M | 02/2012 |
| Post Ipo Debt | $30M | 06/2013 |
| Post Ipo Equity | $4M | 04/2014 |
| Post Ipo Equity | $75M | 05/2014 |
| Post Ipo Debt | $10.9M | 07/2014 |
| Post Ipo Equity | $141.0M | 07/2015 |
| Post Ipo Equity | $57.6M | 10/2015 |
| Post Ipo Debt | $25M | 10/2016 |
| Post Ipo Equity | $5M | 10/2016 |
| Post Ipo Equity | $50M | 08/2017 |
| Grant | $25M | 01/2018 |
| Post Ipo Equity | $46M | 08/2018 |
| Post Ipo Equity | $34M | 04/2019 |
| Post Ipo Equity | $200M | 06/2020 |
| Post Ipo Equity | $300M | 04/2021 |
| Post Ipo Debt | $400M | 11/2021 |
Amyris investors
| Investors | Security type |
|---|---|
| TPG Growth | Series A |
| Kleiner Perkins | Series A |
| Khosla Ventures | Series A |
| DAG Ventures | Series B |
| TPG Growth | Series B |
| Kleiner Perkins | Series B |
| Khosla Ventures | Series B |
| DAG Ventures | Series B |
| TPG Growth | Series B |
| Kleiner Perkins | Series B |
| Khosla Ventures | Series B |
| TPG Growth | Series C |
| Kleiner Perkins | Series C |
| Votorantim Novos Negocios | Series C |
| Khosla Ventures | Series C |
| TotalEnergies Ventures | Series D |
| The Procter & Gamble Company | Series D |
| Cosan | Series D |
| Temasek | Series D |
| Total Gas & Power | Post Ipo Equity |
| Temasek | Post Ipo Equity |
| Biolding Investment | Post Ipo Equity |
| Naxyris | Post Ipo Equity |
| TotalEnergies Ventures | Post Ipo Equity |
| TOTAL SE | Post Ipo Equity |
| Temasek | Post Ipo Equity |
| DSM | Post Ipo Equity |
| Vivo Capital | Post Ipo Equity |
| National Institutes of Health (NIH) | Grant |
| John Doerr | Post Ipo Equity |
| Foris Ventures | Post Ipo Equity |
| Wei Wu He | Post Ipo Equity |
Amyris competitors
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Codexis | $80,636 | $59.3M | 165 | 13 |
| bluebird bio | $98,505 | $3.7M | 518 | 10 |
| 23andMe | $112,477 | $219.6M | 750 | 12 |
| BioReliance | $74,348 | $49.9M | 700 | - |
| Admera Health | $49,775 | $1.0M | 75 | - |
| Celldex Therapeutics | $68,878 | $7.0M | 134 | 4 |
| Nanogen | $54,140 | $8.5M | 10 | - |
| Morphotek | $51,282 | $4.8M | 1 | - |
| Celera | $75,834 | - | 750 | - |
| ABC Laboratories | $72,507 | $72.0M | 3,000 | 3 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Amyris highest paying jobs
Zippia gives an in-depth look into the details of Amyris, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Amyris. The employee data is based on information from people who have self-reported their past or current employments at Amyris. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Amyris. The data presented on this page does not represent the view of Amyris and its employees or that of Zippia.
Amyris may also be known as or be related to AMYRIS, INC., Amyris, Amyris Inc, Amyris Inc. and Amyris, Inc.